Better Buy: Eli Lilly vs. Novo Nordisk. The Answer Is Becoming ...

Dec 26, 2024 · Enter Eli Lilly (LLY-0.24%) and Novo Nordisk (NVO 0.34%), the makers behind blockbuster glucagon-like peptide-1 (GLP-1) agonists such as Mounjaro, Zepbound, Ozempic, …

CouponFollow Extension

24%
OFF

Better Buy: Eli Lilly Vs. Novo Nordisk. The Answer Is Becoming ...

3 weeks from now

Dec 26, 2024 · Enter Eli Lilly (LLY-0.24%) and Novo Nordisk (NVO 0.34%), the makers behind blockbuster glucagon-like peptide-1 (GLP-1) agonists such as Mounjaro, Zepbound, Ozempic, …

fool.com

77%
OFF

Better Buy: Novo Nordisk Vs. Eli Lilly | The Motley Fool

3 weeks from now

While Ozemipc is the brand name on everyone's lips when they talk about weight loss, it's only approved to control blood sugar and reduce the risk of heart attacks for patients with type 2 diabetes. Nevertheless, Ozempic sales soared 77% last year to $8.8 billion with help from off-labelweight-loss prescriptions as well as diabetes patients. Invest...

fool.com

32%
OFF

Better Buy: Eli Lilly Or Novo Nordisk? | The Motley Fool

3 weeks from now

Dec 23, 2024 · In this video, I will cover the recent updates regarding Novo Nordisk (NVO-0.32%) and whether or not the dip is worth buying over Eli Lilly (LLY-1.38%). Watch the short video to …

fool.com

24%
OFF

These 3 Factors Could Make Eli Lilly Stock A Better Buy Than Novo ...

3 weeks from now

Aug 31, 2024 · Eli Lilly (LLY-0.24%) and Novo Nordisk (NVO 0.34%) are big pharma peers. They're also each other's biggest rivals, especially in the all-important market for weight-loss …

fool.com

19%
OFF

Eli Lilly Vs. Novo Nordisk: What's The Better Weight ... - The Motley …

3 weeks from now

Jul 27, 2023 · Two companies that are investing big money in weight-loss treatments are Eli Lilly (LLY-0.19%) and Novo Nordisk (NVO 0.32%). Shares of both companies are up more than …

fool.com

34%
OFF

Why Novo Nordisk Stock Got Destroyed Today, But Eli ... - The …

3 weeks from now

Dec 20, 2024 · Bad news for Novo Nordisk (NVO 0.34%) Friday was good news for Eli Lilly (LLY-0.24%) and Viking Therapeutics (VKTX 1.18%), its two main rivals in the field of weight loss …

fool.com

20%
OFF

Does This News From The FDA Make Eli Lilly A Buy For 2025?

3 weeks from now

Dec 23, 2024 · In a recent head-to-head study involving Novo Nordisk's Wegovy, Zepbound came out on top, resulting in average weight loss of about 20%, compared to more than 13% for the …

fool.com

79%
OFF

2 Pharmaceutical Growth Stocks To Buy Now And Hold For Decades

3 weeks from now

Dec 28, 2024 · Eli Lilly (LLY 0.79%) and Novo Nordisk (NVO 1.74%) have attracted a lot of attention over the past two years thanks to their advances in the weight loss therapy market. …

fool.com

FAQs about Better Buy: Eli Lilly vs. Novo Nordisk. The Answer Is Becoming ... Coupon?

Should I buy Novo Nordisk or Eli Lilly?

While Eli Lilly is the stock I'd rather own right now, a relatively modest valuation makes Novo Nordisk the better buy. Cory Renauer has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Pfizer. The Motley Fool recommends Johnson & Johnson and Novo Nordisk. ...

Are Eli Lilly & Novo Nordisk a big pharma rival?

Eli Lilly (NYSE: LLY) and Novo Nordisk (NYSE: NVO) are big pharma peers. They're also each other's biggest rivals, especially in the all-important market for weight-loss drugs, in which both are currently highly successful. Right now, there are a few reasons to believe that Eli Lilly has the upper hand in this competitive clash. ...

Is Novo Nordisk a good stock to buy now?

While Novo Nordisk is probably the better weight-management stock, a more diverse product lineup and development pipeline make Eli Lilly the better overall pharmaceutical business. A more reasonable valuation makes me want to call Novo Nordisk the better buy now, but that probably isn't the best course of action. ...

Is Eli Lilly a good company?

Much like Novo Nordisk, Eli Lilly's pipeline is chock-full of near-term opportunities to launch winning therapies, and it has a few strong performers in hand as well. ...

Is Eli Lilly a good stock to buy?

Investor enthusiasm for Eli Lilly is so high that by market cap, it's larger than Pfizer and Johnson & Johnson combined. At recent prices, the stock trades for the sky-high multiple of 110 times trailing-12-month earnings. ...

Will Lilly gain market share from Novo Nordisk?

Its primary candidate, orforglipron, has demonstrated some positive indicators during clinical trials. Should orforglipron gain approval from the FDA, Lilly may have an opportunity to gain incremental market share in the weight loss space from its primary competitor, Novo Nordisk. ...